Reunion Neuroscience
Mark Theeuwes is currently serving as the Strategic Advisor at Somnia Therapeutics and as the Chief Operating Officer at Reunion Neuroscience. Mark is also a Member of the Board of Directors at the Epilepsy Foundation and the Principal at Pharmaceutical Services, LLC. With a background in biochemistry and extensive experience in various leadership roles within the pharmaceutical industry, Mark has contributed significantly to organizations such as Egalet Corporation, NPS Pharmaceuticals, and ViroPharma Incorporated.
This person is not in any offices
Reunion Neuroscience
Reunion Neuroscience is committed to innovating therapeutic solutions to treat mental health conditions through the development of novel psychedelic compounds. NASDAQ:REUN